13F Holdings
中文EN

AVTR Avantor, Inc.

Laboratory Analytical Instruments · NYSE · SEC CIK 1722482 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.9%
TTM net income YoY510.2%
TTM EPS YoY484.6%
Revenue 3-yr CAGR-1.9%
Net income 3-yr CAGR-2.5%

Margins

Gross margin31.6%
Operating margin7.3%
Net margin5.1%
FCF margin6.6%
EBITDA margin13.7%

Returns

ROE5.9%
ROA2.9%
ROIC (approx.)5.3%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets49.8%
Debt / equity0.63x
Current ratio1.89x
Interest coverage3.00x

Cash quality & payout

Operating cash flow / net income1.73x
Accruals ratio-2.1%
Payout ratio—
Capex / revenue2.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20202021-12-31
Income statement
Revenue$6.55B$6.78B$6.97B$7.51B$7.39B
Cost of revenue$4.41B$4.50B$4.60B$4.91B$4.88B
Gross profit$2.14B$2.28B$2.36B$2.60B$2.50B
SG&A expense$1.60B$1.64B$1.51B$1.47B$1.53B
Operating income-$246.20M$1.08B$696.40M$1.13B$972.20M
Interest expense$169.80M$218.80M$284.80M$265.80M$217.40M
Pretax income-$441.30M$853.90M$410.50M$851.10M$753.00M
Income tax$88.90M$142.40M$89.40M$164.60M$180.40M
Net income-$530.20M$711.50M$321.10M$686.50M$572.60M
EBITDA$164.00M$1.49B$1.10B$1.54B$1.35B
EPS (basic)-0.781.050.481.020.86
EPS (diluted)-0.781.040.471.010.85
Weighted avg. shares (diluted)680.60M681.90M678.40M679.40M599.60M
Balance sheet
Cash & equivalents$365.40M$264.70M$287.70M$396.90M$327.10M
Receivables$1.07B$1.03B$1.15B$1.22B$1.22B
Inventory$818.20M$731.50M$828.10M$913.50M$872.00M
Current assets$2.45B$2.15B$2.38B$2.66B$2.48B
PP&E, net$766.80M$708.10M$737.50M$727.00M$705.50M
Goodwill$4.99B$5.54B$5.72B$5.65B$5.34B
Intangibles$3.10B$3.27B$3.68B$4.04B$5.05B
Total assets$11.79B$12.11B$12.97B$13.46B$13.90B
Current liabilities$1.38B$2.01B$1.48B$1.66B$1.45B
Short-term debt$30.80M$821.10M$259.90M$364.20M$45.20M
Long-term debt$3.92B$3.23B$5.28B$5.92B$6.98B
Total debt$3.95B$4.06B$5.54B$6.29B$7.02B
Total liabilities$6.23B$6.16B$7.72B$8.61B$9.70B
Shareholders' equity$5.57B$5.96B$5.25B$4.86B$4.20B
Net debt$3.58B$3.79B$5.25B$5.89B$6.70B
Shares outstanding682.00M680.80M676.60M674.30M609.70M
Cash flow statement
Operating cash flow$623.80M$840.80M$870.00M$843.60M$953.60M
Capital expenditure$128.80M$148.80M$146.40M$133.40M$111.10M
Free cash flow$495.00M$692.00M$723.60M$710.20M$842.50M
Investing cash flow-$130.50M$438.90M-$143.70M-$109.60M-$4.12B
Financing cash flow-$409.40M-$1.28B-$843.70M-$648.70M$3.22B
Depreciation & amortization$410.20M$405.50M$402.30M$405.50M$379.20M
Stock-based compensation$46.40M$46.80M$40.50M$45.80M$50.70M
Share buybacks$75.10M$0$0——

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.